T11	Subject 0 40	Six of 13 outpatients with schizophrenia
T12	Treatment 61 97	a ten-week open trial of risperidone
T13	Effect 172 273	intolerable affect, including feelings of agitation and depression and periods of crying and insomnia
T15	Population 0 9	Six of 13
T17	Drug 86 97	risperidone
T18	Duration 61 71	a ten-week
T19	Treat-Disorder 27 40	schizophrenia
T14	Adverse_event 157 168	development
E1	Adverse_event:T14